কিনতে 1 data analytics stock to buy Reuters, 1 to avoid
The adoption of predictive analysis methods in almost every sector using advanced technology relying on big data has made a significant contribution to the growth of the data analytics industry. So, a fundamentally strong stock in this place, Cloudra (NYSE :), is now worth betting on. Conversely, Cardlitics (CDLX) does not appear to be in a good position to capitalize on the industry’s tailwinds due to its weak fundamentals. So it is best to avoid it now. Since the Covid-1 pandemic epidemic is far from over, data analysis among businesses, organizations and communities has accelerated to address disruptive changes and fundamental uncertainties. Several sectors, including retail, healthcare, banking and finance, construction, transportation, and media communications and entertainment, have undertaken data analysis for important strategic initiatives and informed decision making.
According to the International Data Corporation (IDC), global spending on Big Data and Business Analytics (BDA) solutions is expected to reach 21 215.7 billion this year, an increase of 10.1% over 2020. প্রদর্শন 24.63 billion by 2030, showing a 25% CAGR from 2021.
As such, we believe that the data analytics stock Cloudra, Inc. (CLDR) is in a cash position for strong growth prospects in the industry. However, fundamentally weak stocks, Celdex (NASDAQ 🙂 Therapeutics, Inc. (CLDX) may struggle to stay afloat in this place.
Continue reading StockNews
Fusion Media Or anyone involved with Fusion Media will not assume any liability for loss or damage as a result of relying on the information contained in this website, including data, quotes, charts and buy / sell signals. Please be fully aware of the risks and costs associated with trading in the financial markets, this is one of the potential risky investment forms.